The body of fundamental knowledge related to epigenetic modifications of proteins and nucleic acids as well as the mechanisms of epigenetic regulation in organisms ranging from microbes to humans is vast and rapidly expanding. Efforts to translate this knowledge into products and processes that benefit society have rapidly followed this explosion in fundamental understanding of molecular biology.
These products and processes include new medical diagnostics, new ways to treat disease, and enhanced methods of producing therapeutic compounds, proteins, and other lucrative chemical products. EpiBio 2019 explores how to ethically advance interfaces with the epigenome, providing a platform to communicate, share technical knowledge, nucleate collaborations and partnerships, and hear a diverse set of perspectives related to needs, opportunities and priorities at the intersection of bioengineering and epigenetics.